As part of the agreement, Bluejay will be recognized as a strategic partner of BCA member organizations, with BCA referring strategic group purchasing organization (GPO) partners and BCA’s member blood centers to Bluejay. Bluejay gains access to BCA members and their network to offer them Bluejay’s innovative solutions. The collaboration also provides opportunities to support clinical studies and explore direct applications for Symphony in the blood supply industry.
“Bluejay and BCA share the strategic vision of addressing the dire, time-sensitive needs of patients in critical care settings,” said
“BCA is excited to partner with Bluejay to bring innovation that helps support the sustainability of the blood supply,” said
About
BCA is a member-owned organization comprised of more than 60 independent blood centers geographically dispersed throughout
About
About the SymphonyTM System:
Bluejay’s Symphony System (the “Symphony System”) is designed to address the need for simple, reliable, rapid, near-patient testing by providing quantitative measurements of specific biomarkers to determine the need for additional patient care and monitoring. The user-friendly Symphony System will not require any sample preparation or dedicated staff and was shown in published clinical studies to deliver results in approximately 20 minutes.
The Symphony IL-6 Test is a development stage product candidate for investigational use only. It is limited by
Forward-Looking Statements:
This press release contains statements that the Company believes are “forward-looking statements” within the meaning of the Private Litigation Reform Act. Forward-looking statements in this press release include, without limitation, the ability of the Company to submit a marketing application with the FDA in the fourth quarter of 2022, whether the Company’s cash position will be sufficient to fund operations beyond the date of its anticipated regulatory approval and initial commercialization of the Symphony IL-6 Test, and whether such anticipated regulatory approval will actually occur. Forward-looking statements may be identified by words such as “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “seeks,” “should,” “suggest”, “will,” and similar expressions. The Company has based these forward-looking statements on its current expectations and projections about future events, nevertheless, actual results or events could differ materially from the plans, intentions and expectations disclosed in, or implied by, the forward-looking statements the Company makes. These statements are only predictions and involve known and unknown risks, uncertainties, and other factors, including those discussed under item 1A. “Risk Factors” in our most recently filed Form 10-K filed with the
Investor Contact:
alex@lifesciadvisors.com
t: 646-876-3647
Source:
2023 GlobeNewswire, Inc., source